H&H Retirement Design & Management INC Acquires 1,307 Shares of IQVIA Holdings Inc. $IQV

Key Points

• H&H Retirement Design & Management INC increased its stake in IQVIA Holdings Inc. by 32.3%, acquiring an additional 1,307 shares for a total of 5,349 shares worth $850,000.
• Analysts have set a consensus target price of $230.32 for IQVIA, with 18 analysts rating it as a Buy and 7 rating it as Hold.
• IQVIA's stock is currently priced at $200.66, with the company reporting a quarterly revenue of $4.02 billion, beating analyst expectations.

H&H Retirement Design & Management INC boosted its stake in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 32.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,349 shares of the medical research company's stock after purchasing an additional 1,307 shares during the period. H&H Retirement Design & Management INC's holdings in IQVIA were worth $850,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of the business. Everpar Advisors LLC raised its position in shares of IQVIA by 4.6% during the 2nd quarter. Everpar Advisors LLC now owns 1,404 shares of the medical research company's stock valued at $221,000 after buying an additional 62 shares in the last quarter. Ballentine Partners LLC lifted its position in shares of IQVIA by 4.9% in the 1st quarter. Ballentine Partners LLC now owns 1,477 shares of the medical research company's stock worth $260,000 after purchasing an additional 69 shares during the period. Independent Advisor Alliance boosted its position in IQVIA by 4.2% during the 1st quarter. Independent Advisor Alliance now owns 1,801 shares of the medical research company's stock valued at $318,000 after acquiring an additional 72 shares in the last quarter. Nemes Rush Group LLC lifted its position in shares of IQVIA by 15.0% during the first quarter. Nemes Rush Group LLC now owns 621 shares of the medical research company's stock valued at $109,000 after buying an additional 81 shares during the last quarter. Finally, Forte Capital LLC ADV boosted its stake in IQVIA by 0.3% in the second quarter. Forte Capital LLC ADV now owns 26,809 shares of the medical research company's stock valued at $4,225,000 after acquiring an additional 92 shares in the last quarter. 89.62% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have commented on IQV. Weiss Ratings reaffirmed a "hold (c)" rating on shares of IQVIA in a research report on Saturday, September 27th. Truist Financial increased their price objective on IQVIA from $209.00 to $235.00 and gave the company a "buy" rating in a research note on Wednesday, July 23rd. Barclays boosted their target price on shares of IQVIA from $185.00 to $200.00 and gave the company an "equal weight" rating in a report on Thursday, October 2nd. Robert W. Baird lifted their price target on shares of IQVIA from $159.00 to $196.00 and gave the company a "neutral" rating in a research report on Wednesday, July 23rd. Finally, Redburn Partners set a $214.00 target price on IQVIA in a research note on Wednesday, September 3rd. Eighteen investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company's stock. According to MarketBeat.com, IQVIA has a consensus rating of "Moderate Buy" and a consensus target price of $230.32.

IQVIA Stock Down 2.1%

IQVIA stock opened at $200.66 on Wednesday. The company has a debt-to-equity ratio of 2.45, a quick ratio of 0.84 and a current ratio of 0.84. IQVIA Holdings Inc. has a fifty-two week low of $134.65 and a fifty-two week high of $237.34. The firm has a market capitalization of $34.11 billion, a price-to-earnings ratio of 29.04, a price-to-earnings-growth ratio of 2.25 and a beta of 1.32. The stock's fifty day moving average is $188.17 and its two-hundred day moving average is $167.81.

IQVIA (NYSE:IQV - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The medical research company reported $2.81 EPS for the quarter, topping analysts' consensus estimates of $2.77 by $0.04. The business had revenue of $4.02 billion during the quarter, compared to the consensus estimate of $3.96 billion. IQVIA had a net margin of 7.88% and a return on equity of 30.05%. The company's quarterly revenue was up 5.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.64 earnings per share. IQVIA has set its FY 2025 guidance at 11.750-12.050 EPS. Analysts predict that IQVIA Holdings Inc. will post 10.84 EPS for the current fiscal year.

Insider Activity

In related news, insider Eric Sherbet sold 5,800 shares of the business's stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $190.05, for a total transaction of $1,102,290.00. Following the completion of the transaction, the insider owned 27,178 shares in the company, valued at $5,165,178.90. The trade was a 17.59% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Keriann Cherofsky sold 549 shares of the business's stock in a transaction that occurred on Wednesday, July 23rd. The stock was sold at an average price of $191.53, for a total value of $105,149.97. Following the transaction, the insider owned 2,910 shares of the company's stock, valued at approximately $557,352.30. This represents a 15.87% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company's stock.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.

Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for IQVIA Holdings Inc. (NYSE:IQV - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.